VIVEVE MEDICAL, INC. (VIVE) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 93 transactions totaling $13.5M, demonstrating a bullish sentiment with $10.0M in net insider flow. The most recent transaction on Dec 15, 2021 involved a transaction of 36 shares valued at $51.
No significant insider buying has been recorded for VIVE in the recent period.
No significant insider selling has been recorded for VIVE in the recent period.
Based on recent SEC filings, insider sentiment for VIVE is bullish with an Insider Alignment Score of 87/100 and a net flow of $10.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at VIVEVE MEDICAL, INC. (VIVE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading VIVE stock, having executed 93 transactions in the past 90 days. The most active insider is Jon M. Plexico (Executive), who has made 12 transactions totaling $5.0M.
Get notified when executives and directors at VIVE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 15, 2021 | B. Robbins Jim | Executive | Disposition | 36 | $1.43 | $51 | |
| Dec 15, 2021 | Durbin Scott | Executive | Disposition | 2 | $1.40 | $3 | |
| Dec 15, 2021 | L. Basta Steven | Executive | Disposition | 28 | $1.41 | $39 | |
| Oct 1, 2019 | &. Co. Llc Goldman Sachs | Executive | Sale | 25 | $5.77 | $144 | |
| Oct 1, 2019 | &. Co. Llc Goldman Sachs | Executive | Sale | 23,663 | $5.56 | $131.6K | |
| Oct 1, 2019 | &. Co. Llc Goldman Sachs | Executive | Sale | 23,688 | $5.56 | $131.7K | |
| Oct 1, 2019 | Group Inc Goldman Sachs | Executive | Sale | 23,663 | $5.56 | $131.6K | |
| Oct 1, 2019 | Group Inc Goldman Sachs | Executive | Sale | 25 | $5.77 | $144 | |
| Sep 30, 2019 | &. Co. Llc Goldman Sachs | Executive | Sale | 68,737 | $4.55 | $312.8K | |
| Sep 30, 2019 | &. Co. Llc Goldman Sachs | Executive | Sale | 68,737 | $4.55 | $312.8K | |
| Sep 30, 2019 | Group Inc Goldman Sachs | Executive | Sale | 68,737 | $4.55 | $312.8K | |
| Sep 27, 2019 | Group Inc Goldman Sachs | Executive | Sale | 5,359 | $5.10 | $27.3K | |
| Sep 27, 2019 | &. Co. Llc Goldman Sachs | Executive | Sale | 5,359 | $5.10 | $27.3K | |
| Sep 27, 2019 | &. Co. Llc Goldman Sachs | Executive | Sale | 5,359 | $5.02 | $26.9K | |
| Sep 26, 2019 | Group Inc Goldman Sachs | Executive | Sale | 7,001 | $5.25 | $36.8K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 16 | $11.7M | 87.0% |
Sale(S) | 24 | $1.7M | 13.0% |
Disposition(D) | 3 | $94 | 0.0% |
Award(A) | 50 | $0 | 0.0% |
Insiders at VIVEVE MEDICAL, INC. are accumulating shares at an accelerated pace. With 15 insiders making 93 transactions totaling $11.7M in purchases versus $1.7M in sales, the net buying activity of $10.0M signals strong executive confidence. Jon M. Plexico (Executive) leads the buying activity with $5.0M in transactions across all time.